| Drug Name |
Prednisolone sodium phosphate |
| Drug ID |
BADD_D01833 |
| Description |
Prednisolone phosphate is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]
Prednisolone phosphate was granted FDA Approval on 19 December 1973.[L14144] |
| Indications and Usage |
For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02 |
| DrugBank ID |
DB14631
|
| KEGG ID |
D00981
|
| MeSH ID |
C009022
|
| PubChem ID |
441409
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
50383-040; 52128-164; 42799-812; 65089-0007; 66993-844; 62135-330; 59212-700; 71052-610; 42799-813; 50090-1582; 10695-109; 64958-0042; 0121-0759; 59212-702; 24002-0007; 81646-118; 63187-215; 22552-0051; 66993-846; 24208-715; 0121-0777; 67296-1505; 66993-845; 44523-182; 38779-0153; 65162-667; 50090-0955; 59212-701; 62991-1205; 0121-0773; 68788-7708; 49452-5995; 68791-104; 70166-549; 13925-166; 22552-0004; 17856-0759; 0121-0902; 49452-5996; 60432-212; 51927-0050 |
| Synonyms |
prednisolone phosphate | Predsol | prednisolone sodium phosphate | prednisolone phosphate, sodium salt, (11beta)-isomer | prednisolone 21-phosphate sodium | prednisolone phosphate sodium | prednisolone phosphate, monosodium salt, (11beta)-isomer | prednisolone-21-phosphate | Pediapred |
